Q3 2022 Holdings
Filed 2022-11-10 | 8 holdings | $58.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $32.6K | 498,558 | 55.5% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $9.2K | 3,561,150 | 15.6% |
| Passage Bio, Inc. | Common Stock | 702712100 | $6.2K | 4,959,769 | 10.6% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $4.8K | 5,068,233 | 8.2% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $2.6K | 2,320,381 | 4.4% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $1.9K | 543,753 | 3.2% |
| Minerva Surgical Inc. | Common Stock | 60343F106 | $1.3K | 1,673,700 | 2.3% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $121 | 101,855 | 0.2% |